Both Serum Institute of India (SII) and Bharat Biotech would be ramping up production of Covid vaccines in India from July. SII is manufacturing Oxford-AstraZeneca vaccine called Covishield in India, while Bharat Biotech is producing Covaxin.
There are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.
Prime Minister Narendra Modi has asked Health Minister Harsh Vardhan to counter opposition parties' narratives on vaccination with facts.
Around 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.
As the country faces the deadly second wave of coronavirus, India has become the second country after the United States to cross 20 crore cumulative COVID-19 vaccination coverage.
AAP MLA Atishi Marlena has informed that Delhi on Monday received nearly 1.5 lakh doses of Covishield for the 45 plus age group.
According to the health ministry, a total of 19,60,51,962 vaccine doses have been administered through 28,16,725 sessions, as per the provisional report till 7 am today.
A total of 500 Covishield vials have been reported missing from a government hospital in Hyderabad, police said on Friday.
Two doses of the Oxford/AstraZeneca vaccine have shown to prevent around 85 to 90 per cent of symptomatic COVID-19 infections, the first real-world data from Public Health England (PHE) has found.
The Covid-19 Working Group based on the available real-life evidence suggested that the interval should be extended to 12-16 weeks.
External Affairs Minister S Jaishankar will visit the US in the coming week from May 24 to May 28. The official announcement was made by Ministry of External Affairs on Friday.
About 150 Covid vaccination sites have been shut in Delhi from today due to shortage of vaccine.
BJP president JP Nadda said that coronavirus vaccine will be available for all in the country by December.
There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield, respectively. Only three vaccines have so far been approved to be sold in India --- Covaxin, Coveshield and Sputnik V.
Serum Institute of India (SII) CEO Adar Poonawalla said that vaccination in a large populous country such as India won't be possible in 2-3 months.
According to the scientist, vaccine doses will be safe no matter when they are taken but will not provide any great "boosting" if given within less than a month or so of the previous dose.
WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum Institute of India will need to “get back on track and catch up” on its delivery commitments to COVAX, the global initiative to supply coronavirus vaccines to nations around the world.
AAP MLA Atishi Marlena on Monday said that the national capital was running out of vaccine stock. Raising an alarm, Atishi claimed that Delhi has less than a day's stock of Covaxin for 45-plus after Monday evening while Covisheild will last only for five days.
Alerts have been raised in some countries on post-vaccination "embolic and thrombotic events" on 11 March, 2021 particularly with AstraZeneca-Oxford vaccine (Covishield in India).
The first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released on Monday (May 17) by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan, officials said.
Top News
Latest News
